Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAP3K12 |
| Upstream (Parents) |
|---|
| (<<) CD4 → MAP3K12 |
| (<<) CD79A → MAP3K12 |
| (<<) CREB3L1 → MAP3K12 |
| (<<) CRTC1 → MAP3K12 |
| (<<) FER1L4 → MAP3K12 |
| (<<) FLJ35390 → MAP3K12 |
| (<<) GNAI2 → MAP3K12 |
| (<<) GRN → MAP3K12 |
| (<<) IGFBP7 → MAP3K12 |
| (<<) KLF2 → MAP3K12 |
| (<<) MN1 → MAP3K12 |
| (<<) MXRA8 → MAP3K12 |
| (<<) NBL1 → MAP3K12 |
| (<<) NFATC4 → MAP3K12 |
| (<<) PALM → MAP3K12 |
| (<<) RARA → MAP3K12 |
| (<<) RDH16 → MAP3K12 |
| (<<) SEH1L → MAP3K12 |
| (<<) SEMA5B → MAP3K12 |
| (<<) SHFM1 → MAP3K12 |
| (<<) TM4SF1 → MAP3K12 |
| Downstream (Children) |
|---|
| MAP3K12 → CREB3 (>>) |
| MAP3K12 → CTPS (>>) |
| MAP3K12 → FUT1 (>>) |
| MAP3K12 → LYAR (>>) |
| MAP3K12 → PRKCE (>>) |
| MAP3K12 → PRKCZ (>>) |
| MAP3K12 → SGSH (>>) |
| MAP3K12 → STAT6 (>>) |
| MAP3K12 → STYK1 (>>) |
| MAP3K12 → TINF2 (>>) |
